Your browser doesn't support javascript.
loading
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis.
Dai, Jiali; Liu, Xinyin; Li, Jun; Qu, Tianyu; Cui, Yanan; Jin, Shidai; Zhang, Erbao; Guo, Renhua.
Afiliação
  • Dai J; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Liu X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li J; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Qu T; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Cui Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Jin S; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang E; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Guo R; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Thorac Cancer ; 14(6): 535-543, 2023 02.
Article em En | MEDLINE | ID: mdl-36594109

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article